Scout | FY26 Duchenne Muscular Dystrophy Clinical/Translational Research Award (CTRA)

nofo

FY26 Duchenne Muscular Dystrophy Clinical/Translational Research Award (CTRA)

This award funds advanced clinical and translational research to move promising Duchenne muscular dystrophy (DMD) ideas toward clinical applications. Projects must fit at least one FY26 CTRA focus area, with two funding levels for smaller or larger preclinical/clinical work and an optional Partnering PI model for two-investigator collaborations. Preliminary data are required, and pilot trials …

Source

Agency: Defense Health Agency Contracting Activity - DHACA

Award

Total Funding: $8.5M

Dates

Open Date: June 17, 2026

Close Date: September 18, 2026

Eligibility

industry:defense

industry:research

Keywords

duchenne muscular dystrophy

clinical translational research

dmd therapies

preliminary data

partnering pi

pilot clinical trial

translational medicine

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers